e Banco de Sangue, Hospital Nacional Guido Valadares, Dili, Timor-Leste; 4 Menzies School of Health Research, Charles Darwin University, Darwin, Australia *Corresponding author. Tel: !33142160171; Fax: !33142160126; E-mail: gianpiero.tebano@gmail.com Sir, We read with great interest the comprehensive narrative review on antimicrobial resistance in South-East Asia by Zellweger et al. 1 However, the paper did not include any relevant information about Timor-Leste, one of the countries included in the WHO South-East Asia Region.
Timor-Leste has one of the lowest incomes per capita in the region 2 and infectious diseases still account for a substantial burden in terms of both morbidity and mortality. 3 While some data are available about TB, malaria and HIV, 3 little is known about antibiotic resistance.
In order to better explore the epidemiology of antibiotic resistance in Timor-Leste, we performed a systematic review of the literature. Using a combination of terms including TimorLeste/East-Timor and antibiotic/antimicrobial resistance, we systematically searched the MEDLINE, Web of Science, Cochrane Library and Scielo databases from inception until 31 October 2017. Moreover, using the same search terms (and manual search where necessary), we screened: web sites of the Timorese Ministry of Health (MoH), the WHO, the Center for Disease Dynamics, Economics & Policy, the CDC, the ECDC, the Australian Government Department of Health and key regional and international infectious diseases societies; Google Scholar; ResearchGate; and two grey literature search engines (see the Supplementary data available at JAC Online). Each step of the process was carried out by one investigator. We only focused on antibiotic resistance, thus antimycobacterial, antiviral and antiparasitic resistance were not considered.
We obtained 916 articles/web documents and selected 30 of them after title and abstract (where available) screening. The full text of these 30 documents was analysed and finally only one WHO publication and three articles were retained. Two of these papers were published in journals indexed on MEDLINE.
In the most recent article, by Conceição et al., 4 167 inpatients and healthcare workers from two hospitals in the capital, Dili, were screened for Staphylococcus aureus nasal carriage in 2010-14. None of the 22 positive patients harboured MRSA; all isolates were penicillin resistant and 21% were tetracycline resistant. Another article by Conceição et al., 5 published in an unindexed journal, appears to report preliminary results of the same study and it shows the same results concerning Timor-Leste. 4 In a different study, by Oliveira et al., 6 skin swab samples were collected in 2006 from 46 Timorese river buffalos in three farms located in a peripheral district (Lospalos). They identified some Gram-positive bacteria of relevance to human medicine, including CoNS, Micrococcus sp. and Rhodococcus sp. They described a discrete prevalence of resistance to b-lactams (methicillin resistance in 33% and 73% of cocci and bacilli, respectively), but data were presented with various species grouped together, without distinguishing pathogenic from non-pathogenic organisms.
Finally, few data on Timor-Leste were provided in the 2014 WHO Antimicrobial Resistance: Global Report on Surveillance.
7 Data were collected in 2010-12 and came from the National Laboratory only. Resistance to third-generation cephalosporins was reported in 2% of Escherichia coli isolates, methicillin resistance in 25% of S. aureus isolates and resistance, or non-susceptibility, to penicillin in 4% of Streptococcus pneumoniae isolates.
This poor and contrasting evidence would suggest a lower prevalence of antibiotic resistance in Timor-Leste compared with other countries in the region. 1, 7 However, the very limited amount of data, collected with inhomogeneous methods and sampling, does not allow any meaningful conclusions. A recent study has shown high rates of Gram-negative resistance in urine samples, 8 suggesting that antibiotic resistance may be more widespread.
The Timorese National Health System is still in a building phase, after many years of political troubles. As underlined by the WHO in 2016, 9 most of the key actions expected to reach the strategic objectives of the Global Action Plan on Antimicrobial Resistance still need to be put in place. 9 However, many steps forward have been made during recent years. The Laboratorio Nacional de Saude in collaboration with the National Hospital is developing capacity for antimicrobial susceptibility testing for bacterial isolates, MoH-and WHO-guided awareness campaigns have been accomplished and a national drug regulatory authority and a standard treatment guideline for antibiotic use in the National Hospital have been established. Moreover, a National Action Plan on Antimicrobial Resistance: Timor-Leste 2017-2020 10 has been issued, providing a timeline to implement several coordinated actions, including the strengthening of educational activities, the establishment of a national antibiotic resistance surveillance system (by 2019), the reinforcement of hygiene and infection control measures and the implementation of antimicrobial stewardship programmes. These measures should hopefully help to better understand and address antibiotic resistance in Timor-Leste.
